Galderma Launches Sculptra in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets

2025年04月15日 17:48:49 来自: (0)参与

Sculptra, the first proven regenerative biostimulator, will provide new options for patients in China who are looking for innovative treatments to correct mid-facial volume loss and/or contour deficiencies1-7
Sculptra is the only regenerative biostimulator supported by over 25 years of clinical evidence and safety while providing natural-looking results through to two years7-10
Galderma's journey is marked by continuous innovation and expansion, and with this new launch, products from across Galderma’s Injectable Aesthetics portfolio are now available in China, demonstrating its commitment to meeting the needs of even more patients and healthcare professionals

ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation, in China.1-7,11-14 This follows Sculptra’s approval by China’s National Medical Products Administration for correcting mid-facial volume loss and/or contour deficiencies last year. Sculptra – which works with the body’s natural processes to achieve healthier, radiant skin and a more youthful appearance – will now be available in China, where growth of aesthetics has outpaced the global market in the past decade.15-18 This launch is indicative of Galderma’s commitment to expanding its unparalleled aesthetics portfolio into new geographies, in order to meet the needs of even more patients and healthcare professionals.

 

“Sculptra has a unique and rich history spanning over 25 years, and its launch in China signals the start of another chapter in its incredible journey. Patients and healthcare professionals in China will now have access to a premium product, backed by decades of clinical evidence, which can help them achieve their varied aesthetic needs by offering long-lasting and natural-looking results.”

 

BALDO SCASSELLATI SFORZOLINI, M.D., PH.D.

GLOBAL HEAD OF R&D

GALDERMA

 

 

 
相关新闻
猫扑网友:柔眸1  Demon
评论:男女中之所以有纯洁的友谊,是因为女生长得不够漂亮

其它网友:先森,你算个what
评论:这么不要脸,这么没心没肺,你的体重应该会很轻吧

搜狐网友:宿命旳青春ノ
评论:女人最恨的男人是陈世美;男人最喜欢的女人是潘金莲。

本网网友:ゆ.舌尖腥咸
评论:当有人装B的时候、哥总是低下头。不是哥感到羞愧、而是哥在找砖头.

腾讯网友:昔年 °Cold
评论:因最近频繁地震,通往爱情的路已断裂,请您绕道而行

百度网友::Destiny. 宿命。
评论:在身材这个问题上,我是坚决不会承认自己是一个粗人的。

天涯网友:理战  Free
评论:儿子要穷养,长大了才知道奋斗;女儿要富教,长大了才不会被诱惑。

天猫网友:涐哭谁心疼╮
评论:世界上最远的距离不是生与死,而是我在新浪微博,而你却在腾讯微博。

淘宝网友:颠覆 wounded
评论:坐地铁,是一项糅合太极,柔道,缩骨功的综合性运动。

凤凰网友:余存° d3sTiny-
评论:没事的话别来找我,有事那就更别来找我了。

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin